ClinicalTrials.gov
public full text
Public Domain
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Chi-GVM Regimen for the Treatment of R/R PTCL#891656
- Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas#882059
- Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma#902458
- O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma#845538
- Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma#172309
Record · ID 1213507
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive